Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
Go back to Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages| (NASDAQ: QTRX) | Delayed: 3.07 -0.05 (1.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.12 | 52 Week High | $ | |||
| Open | $3.12 | 52 Week Low | $ | |||
| Day High | $3.14 | P/E | N/A | |||
| Day Low | $3.00 | EPS | $ | |||
| Volume | 1,048,068 | |||||
